Cri-report -Edoxaban - Potential Game Changer in Oral Anticoagulant Market

Stroke Prevention in Atrial Fibrillation represents the largest opportunity for the new generation oral anticoagulants, besides a very large prevalence, there is a very clear unmet need.

shanghai, China (prHWY.com) October 14, 2012 - (CRi-report) -Stroke Prevention in Atrial Fibrillation represents the largest opportunity for the new

generation oral anticoagulants, besides a very large prevalence, there is a very clear unmet need. There are

1.7 million patients in the US treated for non-valvular atrial Fibrillation with warfarin, in Europe the

prevalence is almost twice and in Japan there are close to million patients.

Full report: http://www.cri-report.com/5488-edoxaban-potential-game-changer-in-oral-anticoagulant-market.html

About 35% of the AF patients are currently not treated with warfarin because of warfarin related constraints

(drug-drug /dietary interactions, difficulty in INR control). Hypothetically assuming a 100% market share

shift from warfarin/aspirin/other therapies to new generation oral anticoagulants, the annual market size

works out to be $22b (at $3000 as annual cost of therapy). Besides the new generation oral anticoagulants,

there is also the watchman device (currently in Phase 3) from Boston Scientific, which as well could be a

major contender of market share.

The recent complete response issued by the USFDA to Eliquis was very much unexpected and has added

uncertainty to the forecasts around this class. We see Daiichi Sankyo's Edoxaban and Boston Scientific's

watchman device as potentially underestimated threat in the consensus forecasts for the new generation oral

anticoagulants.

This report also has a market model for the new generation oral anti coagulants. The market model has been

categorized into three segments.

Full report: http://www.cri-report.com/5488-edoxaban-potential-game-changer-in-oral-anticoagulant-market.html

###

Tag Words: edoxaban, oral anticoagulants, stroke prevention, atrial fibrillation, opportunities, market share, market forecast, report

Categories: Business

Link To This Press Release:

URL HTML Code